To further investigate the impact of Stigmasterol and JAK3 expression on the tumor formation ability of BCSCs in vivo, we first established the JAK3 stably overexpressed BCSCs (4T1 sorted BCSCs). The gene discussed is JAK3; the disease is neoplasm.